Sandercock Colin bought CUE
September 26, 2025 · Form 4 insider transaction
Sandercock Colin bought 30,000 shares of Cue Biopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 70 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,000
Price
$0.00
Total value
N/A
InsiderSandercock Colin
RoleOfficer
CompanyCue Biopharma, Inc. (CUE)
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateSeptember 26, 2025
Filing dateDecember 5, 2025
Shares owned after30,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On July 24, 2024 the Reporting Person was granted an option with vesting subject to the satisfaction of performance-based vesting criteria. The performance-based vesting criteria for these shares was deemed satisfied or waived on September 26, 2025 and these shares underlying the option vested.